BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

The Day In Review: AstraZeneca PLC (AZN) Enters Two Partnerships


1/31/2007 5:00:15 PM

January 31, 2007 -- AstraZeneca signed two drug development deals, one with Argenta Discovery for chronic obstructive pulmonary disease, and the other with Palatin for obesity; Curis and Genentech began a Phase I test of a Hedgehog antagonist for cancer; Pharmion said the FDA accepted its IND for an oral formulation of azacitidine; Avanir received an approvable letter for an orally disintegrating form of FazaClo, or clozapine; and Sepracor handily beat estimates for Q4 but warned revenues would slip in the first half of 2007. The Centient Biotech 200™ rose 8 points to 4042, an increase of .20%. More details...


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->